Get the Stockscreener App
44.51
1.69%
0.74
After Hours:
44.51
Qiagen Nv Stock (QGEN) Latest News
Is QIAGEN Stock an Apt Pick for Your Portfolio Right Now? - Yahoo Finance
Exchange Traded Concepts LLC Sells 258,335 Shares of Qiagen (NYSE:QGEN) - MarketBeat
[Latest] Global Single Cell Multiomics Market Size/Share Worth USD 18.90 Billion by 2033 at a 19.58% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire Inc.
Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Qiagen N : VENLO -January 29, 2025 at 06:08 am EST - Marketscreener.com
Qiagen’s Institutional Investment Spotlight: BlackRock’s Voting Rights Revealed - TipRanks
Qiagen Insiders Sell US$7.0m Of Stock, Possibly Signalling Caution - Simply Wall St
Fifth Third Bancorp Lowers Position in Qiagen (NYSE:QGEN) - MarketBeat
REVERSE SPLIT WITH CHANGE OF ISIN AND SHORT CODE PLUS DIVIDEND: QIAGEN NV - Wiener Börse
RNA Editing Market Top Companies StudyQIAGEN N.V., UniquQuire - openPR
Park Avenue Securities LLC Buys 2,166 Shares of Qiagen (NYSE:QGEN) - Defense World
Qiagen (NYSE:QGEN) Shares Bought by Assenagon Asset Management S.A. - Defense World
SG Americas Securities LLC Reduces Holdings in Qiagen (NYSE:QGEN) - MarketBeat
Crossmark Global Holdings Inc. Sells 18,306 Shares of Qiagen (NYSE:QGEN) - MarketBeat
Qiagen stock hits 52-week high at $47.45 amid steady growth - Investing.com Australia
Qiagen (NYSE:QGEN) Sets New 52-Week HighTime to Buy? - MarketBeat
Genetic Testing Market Projected To Witness Substantial Growth, 2025-2032: Eurofins Scientific, Illumina Inc., - EIN News
QGEN Stock Might Rise Following Partnership With Genomics England - MSN
Strategic Collaborations Aid QGEN Stock Amid Competition - Yahoo Finance
Qiagen (NYSE:QGEN) Short Interest Update - MarketBeat
QIAGEN Finalizes $300 Million Synthetic Share Repurchase Plan - TipRanks
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $300 Million - Silicon Canals
Qiagen Announces BlackRock’s Significant Voting Rights in Recent AFM Disclosure - TipRanks
Qiagen N.V. Voting Rights Update: BlackRock’s Significant Stake Disclosed - TipRanks
QIAGEN N.V. to Release Results for Q4 2024 and Hold Webcast - BioSpace
Qiagen N : Ad hoc Announcement according to Art. 17 Market Abuse Regulation - Marketscreener.com
QIAGEN Announces $300 Million Synthetic Share Repurchase Plan - TipRanks
Qiage announces $300M buyback plan - MSN
QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples - Marketscreener.com
QIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share Repurchase - BioSpace
EQS-Adhoc: QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase - sharewise
New Product Offerings Support QIAGEN's Shares Amid Currency Woes - MSN
QIAGEN Unveils New $300M Share Buyback Plan, Accelerating $1B Shareholder Return Strategy - StockTitan
Qiagen Announces BlackRock’s Significant Stake in Company - TipRanks
Qiagen N.V.'s (NYSE:QGEN) Share Price Not Quite Adding Up - Simply Wall St
QGENQIAGEN N.V. Latest Stock News & Market Updates - StockTitan
Qiagen scoops FDA clearance for gastrointestinal panel - Medical Device Network
QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights from Biological Samples - Marketscreener.com
QIAGEN Doubles Digital PCR Capabilities: QIAcuity Now Analyzes 12 Targets Simultaneously - StockTitan
QIAGEN secures U.S. clearance for first QIAstat-Dx mini gastrointestinal panel to support year-round outpatient care - DutchNews.nl
QIAGEN Secures FDA Clearance for Groundbreaking Rapid Gastrointestinal Test Panel - StockTitan
Will Qiagen (QGEN) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Qiagen (NYSE:QGEN) Receives $51.50 Consensus Target Price from Brokerages - MarketBeat
BlackRock’s Significant Stake Announcement in Qiagen - TipRanks
QIAGEN Supports UK Initiative to Sequence Genomes of 100,000 Newborns With Expert-Curated Genomic Content - sharewise
Qiagen (NYSE:QGEN) Given Equal Weight Rating at Morgan Stanley - MarketBeat
2.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):